Ophthalmic Case Studies and Novel Approach

Track:25-Ophthalmic Case Studies and Novel Approach
In a small randomized controlled trial, production of aqueous tears and secretion of goblet cells increased following application of the Oculeve Intranasal Lacrimal Neurostimulator (Allergan).1 This handheld device works by delivering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve in the nasal cavities. It potentially offers a new mechanism for treating dry eye disease—now largely managed with artificial tears and anti-inflammatory agents.


    Related Conference of Ophthalmic Case Studies and Novel Approach

    November 23-24, 2020

    3rd World Congress on Eye and Vision

    Istanbul, Turkey
    November 23-24, 2020

    3rd World Eye and Vision Congress

    Istanbul, Turkey
    November 23-24, 2020

    34th European Ophthalmology Congress

    Rome, Italy
    December 07-08, 2020

    4th Annual Conference on Orthopedics, Rheumatology and Osteoporosis

    Prague, Czech Republic
    March 08-09, 2021

    6th Global Pediatric Ophthalmology Congress

    Rome, Italy
    March 17-18, 2021

    European Conference on Ophthalmology & Eye care

    Budapest, Aland Islands
    July 29-30, 2021

    2nd International Conference on Glaucoma

    London, UK
    July 29-30, 2021

    2nd International Conference on Optometry

    London, UK
    August 23-24, 2021

    21st Global Ophthalmologists Annual meeting

    London, UK
    August 23-24, 2021

    2nd World Congress on Ophthalmology & Optometry

    London, UK
    September 27-28, 2021

    31th International Congress on VisionScience and Eye

    Dublin, Ireland

    Ophthalmic Case Studies and Novel Approach Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in